[HTML][HTML] Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA

Y Wang, X Meng, A Wang, X Xie, Y Pan… - … England Journal of …, 2021 - Mass Medical Soc
Background Comparisons between ticagrelor and clopidogrel for the secondary prevention
of stroke in CYP2C19 loss-of-function carriers have not been extensively performed …

Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack

Y Wang, X Zhao, J Lin, H Li, SC Johnston, Y Lin, Y Pan… - Jama, 2016 - jamanetwork.com
Importance Data are limited regarding the association betweenCYP2C19genetic variants
and clinical outcomes of patients with minor stroke or transient ischemic attack treated with …

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient …

Y Wang, J Jing, X Meng, Y Pan, Y Wang… - Stroke and vascular …, 2019 - svn.bmj.com
Background and purpose Stroke is the leading cause of mortality and disability in China.
Precise aetiological classification, imaging and biological markers may predict the prognosis …

Dual antiplatelet treatment up to 72 hours after ischemic stroke

Y Gao, W Chen, Y Pan, J Jing, C Wang… - … England Journal of …, 2023 - Mass Medical Soc
Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint …

Y Wang, W Chen, Y Lin, X Meng, G Chen, Z Wang… - bmj, 2019 - bmj.com
Objective To test the hypothesis that ticagrelor plus aspirin is safe and superior to
clopidogrel plus aspirin for reducing high platelet reactivity at 90 days and stroke recurrence …

[HTML][HTML] Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study

J Li, J Lin, Y Pan, M Wang, X Meng, H Li… - Journal of …, 2022 - Springer
Objective Contribution of individual and combined inflammatory markers in prognosis after
stroke was still undefined. We aimed to investigate the association of systemic and local …

High-sensitive C-reactive protein predicts recurrent stroke and poor functional outcome: subanalysis of the clopidogrel in high-risk patients with acute nondisabling …

J Li, X Zhao, X Meng, J Lin, L Liu, C Wang, A Wang… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Minor stroke and transient ischemic attack are common
disorders with high rate of subsequent disabling stroke. We aim to investigate the role of …

[HTML][HTML] The STROMICS genome study: deep whole-genome sequencing and analysis of 10K Chinese patients with ischemic stroke reveal complex genetic and …

S Cheng, Z Xu, S Bian, X Chen, Y Shi, Y Li, Y Duan… - Cell Discovery, 2023 - nature.com
Ischemic stroke is a leading cause of global mortality and long-term disability. However,
there is a paucity of whole-genome sequencing studies on ischemic stroke, resulting in …

[HTML][HTML] Residual inflammatory risk predicts poor prognosis in acute ischemic stroke or transient ischemic attack patients

J Li, Y Pan, J Xu, S Li, M Wang, K Quan, X Meng, H Li… - Stroke, 2021 - journals.lww.com
Background and Purpose: It is still unclear whether the residual cholesterol and
inflammatory risk in the acute phase is associated with prognosis of stroke. We aimed to …

Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke

J Lin, H Zheng, BL Cucchiara, J Li, X Zhao, X Liang… - Neurology, 2015 - AAN Enterprises
Objective: To determine the association of lipoprotein-associated phospholipase A2 (Lp-
PLA2) measured in the acute period and the short-term risk of recurrent vascular events in …